- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 19, 1999
Commission file number 0-17714
BIOPOOL INTERNATIONAL, INC.
(Exact name of Registrant as specified in its charter)
Delaware 58-1729436
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
6025 Nicolle Street
Ventura, California 93003
(Address of principal executive offices)
(805) 654-0643
(Registrant's telephone number including area code)
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
ITEM 5. OTHER EVENTS
Reference is made to the press release of Registrant, issued on April 19,
1999, which contains information meeting the requirements of this Item 5, and
which is incorporated herein by this reference. A copy of the press release is
attached to this Form 8-K as Exhibit "A."
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: April 20, 1999 BIOPOOL INTERNATIONAL, INC.
--------------- ---------------------------
(Registrant)
/s/ Michael D. Bick, Ph.D.
---------------------------
Michael D. Bick, Ph.D.
Chief Executive Officer and
Chairman of the Board
2
<PAGE>
EXHIBIT A
CONTACTS: Michael D. Bick, Ph.D.
Chairman and Chief Executive Officer
Carol Hill
Corporate Communications
(805) 654-0643
FOR IMMEDIATE RELEASE
BIOPOOL INTERNATIONAL TO TRADE ON OTC BULLETIN BOARD
VENTURA, California (April 19, 1999)--Biopool International, Inc. (OTCBB:BIPL)
today announced that effective this date its shares will no longer trade on the
Nasdaq's SmallCap Market because the bid price for its shares has fallen below
the $1.00 per share Nasdaq minimum listing maintenance requirement.
The Company's stock now immediately qualifies to trade on the OTC
Bulletin Board under the symbol "BIPL." Michael D. Bick, Ph.D., chairman and
chief executive officer of Biopool, commented, "The move to the OTC Bulletin
Board in no way reflects any adverse financial conditions within the Company.
Indeed we meet and exceed all listing requirements for Nasdaq other than the $1
minimum bid price."
Founded in 1987, Biopool International develops, manufactures, and
markets a full range of test kits to assess and diagnose disorders of blood
coagulation, thrombotic risk factors, fibrinolysis, platelet function, and the
vascular system and specialty chemistry controls used to monitor and measure the
presence of drugs of abuse. The Company's product line is sold to hospitals,
clinical laboratories, commercial reference laboratories, and research
institutions on a worldwide basis by the Company's own sales representatives, as
well as through an extensive network of distributors. To learn more about
Biopool, visit the Company's website at http://www.biopool.com.
NOTE: This press release contains forward-looking statements which are based
upon current expectations that involve a number of risks and uncertainties
including, but not limited to, technological innovations of competitors, changes
in health care regulations, litigation claims, foreign currency fluctuation,
product acceptance or changes in government regulation of the Company's
products, as well as other factors discussed in the Company's last Report on
Form 10-K-SB under "Risk Factors."
# # #
3
